Accenture plc (ACN) Analysts See $1.66 EPS; Merit Medical Systems Has 1.49 Sentiment

December 8, 2017 - By Dolores Ford

Merit Medical Systems, Inc. designs, develops, makes, and markets medical products for interventional and diagnostic procedures worldwide. The company has market cap of $2.20 billion. The companyÂ’s Cardiovascular segment offers cardiology and radiology devices for diagnosing and treating coronary arterial, peripheral vascular, and other non-vascular diseases; and embolotherapeutic products. It has a 74.7 P/E ratio. It also provides vascular access products; guide wires, inflation devices, and diagnostic catheters for use in angiography procedures; therapeutic infusion systems and safety products; drainage catheters and drainage access products, support catheters, vascular retrieval devices, and dialysis access products; and embosphere microspheres and delivery systems, and microcatheters.

Analysts expect Accenture plc (NYSE:ACN) to report $1.66 EPS on December, 20.They anticipate $0.08 EPS change or 5.06% from last quarter’s $1.58 EPS. ACN’s profit would be $1.02 billion giving it 22.38 P/E if the $1.66 EPS is correct. After having $1.48 EPS previously, Accenture plc’s analysts see 12.16% EPS growth. The stock increased 0.22% or $0.33 during the last trading session, reaching $148.6. About 1.53 million shares traded. Accenture plc (NYSE:ACN) has risen 4.27% since December 8, 2016 and is uptrending. It has underperformed by 12.43% the S&P500.

Accenture plc provides consulting, technology, and outsourcing services worldwide. The company has market cap of $91.35 billion. The Company’s Communications, Media & Technology segment provides professional services that help clients accelerate and deliver digital transformation, and enhance business results through industry-specific solutions; and serves clients in communications, electronics, high technology, media, and entertainment industries. It has a 27.31 P/E ratio. The companyÂ’s Financial Services segment offers services that help clients enhance cost efficiency, grow their customer base, manage risk, and transform their operations; and serves clients in banking, capital markets, and insurance industries.

Among 26 analysts covering Accenture Plc (NYSE:ACN), 14 have Buy rating, 1 Sell and 11 Hold. Therefore 54% are positive. Accenture Plc had 72 analyst reports since August 12, 2015 according to SRatingsIntel. The firm earned “Equal-Weight” rating on Monday, September 21 by Barclays Capital. SunTrust maintained it with “Hold” rating and $130.0 target in Friday, September 29 report. On Thursday, September 7 the stock rating was maintained by Stifel Nicolaus with “Buy”. Cowen & Co maintained the shares of ACN in report on Tuesday, May 31 with “Outperform” rating. The rating was maintained by JP Morgan on Monday, March 28 with “Overweight”. The firm has “Hold” rating by BMO Capital Markets given on Friday, March 24. Robert W. Baird maintained it with “Hold” rating and $148.0 target in Thursday, September 21 report. The company was downgraded on Thursday, September 28 by Societe Generale. The firm has “Buy” rating by Cowen & Co given on Monday, October 23. Societe Generale upgraded Accenture plc (NYSE:ACN) on Monday, September 26 to “Buy” rating.

Investors sentiment increased to 1.05 in 2017 Q2. Its up 0.12, from 0.93 in 2017Q1. It is positive, as 49 investors sold Accenture plc shares while 348 reduced holdings. 82 funds opened positions while 334 raised stakes. 466.45 million shares or 0.50% more from 464.13 million shares in 2017Q1 were reported. New York-based Park Avenue Secs Ltd Limited Liability Company has invested 0.08% in Accenture plc (NYSE:ACN). Rock Point Advsrs Limited owns 3.01% invested in Accenture plc (NYSE:ACN) for 51,717 shares. Moreover, Mariner Wealth Advsr Lc has 0.07% invested in Accenture plc (NYSE:ACN) for 11,462 shares. Naples Glob Ltd Liability Corp reported 0.88% in Accenture plc (NYSE:ACN). Loring Wolcott Coolidge Fiduciary Advsr Llp Ma reported 142,303 shares or 0.36% of all its holdings. Moreover, Laurel Grove Cap Limited Liability Company has 1.24% invested in Accenture plc (NYSE:ACN). Woodley Farra Manion Management reported 251,692 shares. Marco Mngmt Ltd Limited Liability Company invested in 19,900 shares. Kcm Inv Advisors Limited Liability Company invested in 35,657 shares. Winslow Evans & Crocker holds 0% of its portfolio in Accenture plc (NYSE:ACN) for 2,768 shares. House Limited Company accumulated 103,153 shares. Boston Rech And invested in 1.89% or 28,181 shares. Columbia Asset Mgmt holds 0.08% of its portfolio in Accenture plc (NYSE:ACN) for 1,913 shares. Utah Retirement reported 113,617 shares. Massachusetts-based Wilkins Investment Counsel Inc has invested 2.15% in Accenture plc (NYSE:ACN).

Aristotle Capital Boston Llc holds 2.38% of its portfolio in Merit Medical Systems, Inc. for 559,400 shares. Eagle Boston Investment Management Inc owns 536,630 shares or 2.22% of their US portfolio. Moreover, Timpani Capital Management Llc has 1.61% invested in the company for 113,437 shares. The Connecticut-based Thomson Horstmann & Bryant Inc has invested 1.57% in the stock. Ami Asset Management Corp, a California-based fund reported 417,791 shares.

Analysts await Merit Medical Systems, Inc. (NASDAQ:MMSI) to report earnings on February, 20. They expect $0.32 earnings per share, up 3.23% or $0.01 from last year’s $0.31 per share. MMSI’s profit will be $16.06M for 34.26 P/E if the $0.32 EPS becomes a reality. After $0.32 actual earnings per share reported by Merit Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.